Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BIOQ Bioqual	$43.19	$43.56	$43.19 ▼ $72.50	$38.63M	-0.12	N/A	N/A
HQI HireQuest	$9.80 +4.1%	$9.96	$8.94 ▼ $15.75	$138.18M	1.22	11,354 shs	12,329 shs
MXCT MaxCyte	$1.42	$1.98	$1.26 ▼ $5.20	$151.38M	1.23	1.16 million shs	2.01 million shs
SKLZ Skillz	$8.56 +1.4%	$7.41	$3.54 ▼ $9.11	$149.56M	2.8	105,803 shs	81,252 shs

10 Best Stocks to Own: Fall 2025

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BIOQ Bioqual	0.00%	0.00%	0.00%	-4.02%	-38.30%
HQI HireQuest	0.00%	+1.45%	-5.31%	+5.95%	-23.79%
MXCT MaxCyte	0.00%	+4.41%	-37.44%	-35.16%	-66.59%
SKLZ Skillz	0.00%	-4.20%	+5.49%	+40.82%	+37.54%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
BIOQ Bioqual	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
HQI HireQuest	2.6963 of 5 stars	3.5	1.0	1.7	0.0	0.0	1.7	1.9
MXCT MaxCyte	2.7269 of 5 stars	3.3	2.0	0.0	0.0	1.1	3.3	1.3
SKLZ Skillz	2.5579 of 5 stars	3.5	1.0	0.0	0.0	2.4	1.7	1.3

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
BIOQ Bioqual	0.00	N/A	N/A	N/A
HQI HireQuest	3.00	Buy	$13.00	32.65% Upside
MXCT MaxCyte	2.50	Moderate Buy	$7.00	392.96% Upside
SKLZ Skillz	3.00	Buy	$15.00	75.34% Upside

Current Analyst Ratings Breakdown

Latest BIOQ, MXCT, SKLZ, and HQI Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
8/11/2025	MXCT MaxCyte	BTIG Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Neutral
8/7/2025	MXCT MaxCyte	William Blair Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Outperform ➝ Market Perform
8/4/2025	SKLZ Skillz	Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Outperform ➝ Outperform	$15.00
7/22/2025	MXCT MaxCyte	Stephens Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Overweight	$6.00
7/1/2025	SKLZ Skillz	Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Strong-Buy

(Data available from 8/24/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
BIOQ Bioqual	$58.59M	0.66	N/A	N/A	N/A	∞
HQI HireQuest	$34.60M	3.99	$1.34 per share	7.32	$4.63 per share	2.12
MXCT MaxCyte	$38.63M	3.92	N/A	N/A	$1.95 per share	0.73
SKLZ Skillz	$95.47M	1.56	N/A	N/A	$9.81 per share	0.87

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
BIOQ Bioqual	$480K	-$2.39	0.00	∞	N/A	-4.34%	-5.82%	-3.79%	10/20/2025 (Estimated)
HQI HireQuest	$3.67M	$0.18	15.31	11.81	N/A	7.47%	13.88%	9.35%	11/6/2025 (Estimated)
MXCT MaxCyte	-$41.06M	-$0.43	0.00	N/A	N/A	-125.22%	-22.12%	-19.10%	11/5/2025 (Estimated)
SKLZ Skillz	-$48.23M	-$4.20	0.00	N/A	N/A	-75.38%	-39.99%	-20.44%	11/6/2025 (Estimated)

Latest BIOQ, MXCT, SKLZ, and HQI Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/7/2025	Q2 2025	HQI HireQuest	$0.11	$0.15	+$0.04	$0.08	$7.66 million	$7.64 million
8/7/2025	Q2 2025	SKLZ Skillz	-$1.34	-$1.12	+$0.22	-$0.58	$22.80 million	$27.37 million
8/6/2025	Q2 2025	MXCT MaxCyte	-$0.10	-$0.12	-$0.02	-$0.12	$9.57 million	$8.51 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
BIOQ Bioqual	$0.50	1.16%	N/A	N/A	N/A
HQI HireQuest	$0.24	2.45%	N/A	133.33%	N/A
MXCT MaxCyte	N/A	N/A	N/A	N/A	N/A
SKLZ Skillz	N/A	N/A	N/A	N/A	N/A

Latest BIOQ, MXCT, SKLZ, and HQI Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
8/11/2025	HQI HireQuest	quarterly	$0.06	2.5%	8/29/2025	9/1/2025	9/15/2025

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
BIOQ Bioqual	N/A	5.08	5.08
HQI HireQuest	N/A	2.23	2.23
MXCT MaxCyte	N/A	12.40	11.71
SKLZ Skillz	N/A	N/A	N/A

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
BIOQ Bioqual	N/A
HQI HireQuest	12.00%
MXCT MaxCyte	68.81%
SKLZ Skillz	19.42%

Insider Ownership

Company	Insider Ownership
BIOQ Bioqual	39.24%
HQI HireQuest	43.50%
MXCT MaxCyte	3.30%
SKLZ Skillz	30.42%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
BIOQ Bioqual	114	890,000	543,000	Not Optionable
HQI HireQuest	65,000	14.10 million	7.97 million	Not Optionable
MXCT MaxCyte	80	106.61 million	103.09 million	Optionable
SKLZ Skillz	650	17.43 million	12.13 million	Optionable

BIOQ, MXCT, SKLZ, and HQI Headlines

Recent News About These Companies

Skillz (NYSE:SKLZ) Trading 0% Higher - Should You Buy?

August 24 at 2:06 AM | marketbeat.com

Skillz (SKLZ) Q2 Revenue Jumps 8%

August 16, 2025 | theglobeandmail.com

5 Insightful Analyst Questions From Skillz’s Q2 Earnings Call

August 14, 2025 | finance.yahoo.com

Skillz Inc. (NYSE:SKLZ) Q2 2025 Earnings Call Transcript

August 9, 2025 | msn.com

Skillz’s (NYSE:SKLZ) Q2: Strong Sales, Stock Soars

August 9, 2025 | msn.com

Skillz Inc. (SKLZ) Q2 2025 Earnings Call Transcript

August 7, 2025 | seekingalpha.com

Skillz Inc. (SKLZ) Reports Q2 Loss, Tops Revenue Estimates

August 7, 2025 | zacks.com

Skillz Announces Preliminary Second Quarter 2025 Results

August 7, 2025 | businesswire.com

Skillz (NYSE:SKLZ) Given Outperform Rating at Wedbush

August 5, 2025 | marketbeat.com

3 Cash-Heavy Stocks We Keep Off Our Radar

August 4, 2025 | finance.yahoo.com

Skillz to Report 2025 Second Quarter Results on August 7 and Host Conference Call and Webcast

July 31, 2025 | uk.finance.yahoo.com

Earnings Preview: Skillz Inc. (SKLZ) Q2 Earnings Expected to Decline

July 31, 2025 | zacks.com

Skillz (SKLZ) Projected to Post Earnings on Thursday

July 31, 2025 | marketbeat.com

Skillz (NYSE:SKLZ) Trading Up 4.6% - Here's What Happened

July 26, 2025 | marketbeat.com

Video Gaming Stocks Q1 Recap: Benchmarking Take-Two (NASDAQ:TTWO)

July 24, 2025 | msn.com

Why Is Skillz (SKLZ) Stock Soaring Today

July 24, 2025 | msn.com

Skillz (SKLZ) Surges 10.1%: Is This an Indication of Further Gains?

July 23, 2025 | zacks.com

3 Cash-Burning Stocks with Open Questions

July 16, 2025 | finance.yahoo.com

Skillz Inc. (SKLZ) Latest Stock News & Headlines - Yahoo Finance

July 11, 2025 | finance.yahoo.com

Skillz’s Q1 Earnings Call: Our Top 5 Analyst Questions

June 30, 2025 | msn.com

SKLZ Stock - Skillz Inc Ordinary Shares Class A - Morningstar

June 26, 2025 | morningstar.comM

New MarketBeat Followers Over Time

Media Sentiment Over Time

BIOQ, MXCT, SKLZ, and HQI Company Descriptions

Bioqual OTCMKTS:BIOQ

$43.19 0.00 (0.00%)

As of 08/22/2025

Bioqual, Inc. provides in-vivo and in-vitro pre-clinical research services to commercial and government clients in the United States. The company provides research services in the areas of COVID-19, AIDS, influenza, RSV infection, and flavivirus infections, including zika, dengue, malaria, hepatitis, and cancer. Its services also include sample processing, virus stock generation, quantitation of infectious virus, virus neutralization assays, hemagglutination inhibition assay, quantitative PCR, antigen and antibody ELISA detection assays, flow cytometry, lymphocyte proliferation, and other cell-based assays. In addition, the company provides animal research model related services. Bioqual, Inc. was founded in 1981 and is based in Rockville, Maryland.

HireQuest NASDAQ:HQI

$9.80 +0.39 (+4.14%)

Closing price 08/22/2025 04:00 PM Eastern

Extended Trading

$9.78 -0.03 (-0.26%)

As of 08/22/2025 04:10 PM Eastern

HireQuest, Inc. provides temporary staffing services in the United States. It offers staffing services, including direct-dispatch, executive search, consultant, unskilled and semi-skilled industrial and construction personnel, clerical and administrative personnel, and permanent placement services, as well as commercial and non-CDL drivers, and skilled personnel in the medical and dental industries. The company provides its services under the HireQuest Direct, HireQuest, SNelling, DriverQuest, HireQuest Health, Northbound Executive Search, and MRI trade names. It serves construction, recycling, warehousing, logistics, auctioneering, manufacturing, hospitality, landscaping, and retail industries, as well as dental practices. HireQuest, Inc. was founded in 2002 and is headquartered in Goose Creek, South Carolina.

MaxCyte NASDAQ:MXCT

$1.42 0.00 (0.00%)

Closing price 08/22/2025 04:00 PM Eastern

Extended Trading

$1.46 +0.04 (+2.82%)

As of 08/22/2025 06:29 PM Eastern

MaxCyte, Inc., a life sciences company, discovers, develops, and commercializes next-generation cell therapies in the United States and internationally. Its products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expression of therapeutic targets for cell-based assays; ExPERT GTx, a flow electroporation for large scale transfection in therapeutic applications; and ExPERT VLx for very large volume cell-engineering. The company also provides disposable processing assemblies (PAs) to process and electroporate cells; and accessories supporting PAs, such as electroporation buffer solution and software protocols. It licenses and sells its instruments and technology; and sells its consumables to developers of cell therapies, as well as to pharmaceutical and biotechnology companies for use in drug discovery and development, and bio-manufacturing. MaxCyte, Inc. was incorporated in 1998 and is headquartered in Rockville, Maryland.

Skillz NYSE:SKLZ

$8.56 +0.12 (+1.36%)

Closing price 08/22/2025 03:59 PM Eastern

Extended Trading

$8.58 +0.03 (+0.29%)

As of 08/22/2025 06:29 PM Eastern

Skillz Inc. operates a mobile game platform in the United States and internationally. The company primarily develops and supports a proprietary online-hosted technology platform that enables independent game developers to host tournaments and provide competitive gaming activity to end-users. The company distributes games through direct app download from its website, as well as through third-party platforms. Skillz Inc. was founded in 2012 and is based in San Francisco, California.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time